About David Parkinson
David Parkinson is a director at Angiocrine Bioscience.
David Parkinson first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name David Parkinson in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Parkinson works with at each company, as listed on that company's latest Form D.
Angiocrine Bioscience, Inc. · Form D, Sep 5, 2025
Jeffrey Port
Director
JL
John Lomoro
Chief Financial Officer/Treasurer
PF
Paul Finnegan
President/Chief Executive Officer and director
JJ
John Jaskowiak
Chief Operating Officer/Secretary